Protease Serine (PRSS)
Showing 1 - 25 of 713
Covid19 Trial in South Africa, United States (Part A: Upamostat 200 mg, Part A: Upamostat 400 mg, Part A and B: Placebo)
Suspended
- Covid19
- Part A: Upamostat 200 mg
- +3 more
-
Cutler Bay, Florida
- +16 more
Aug 2, 2022
Rosacea Trial in San Diego (Ivermectin)
Completed
- Rosacea
-
San Diego, CaliforniaUCSD Division of Dermatology
Oct 1, 2021
Angiotensin-converting Enzyme 2 Expression in Tonsils and
Withdrawn
- Adenoidectomy
- Tonsillectomy
- Storage of operating waste
-
Créteil, France
- +8 more
Jul 5, 2021
Covid19 Trial (Aerosolized 13 cis retinoic acid plus Inhalation administration by nebulization captopril 25mg, Drug: Standard
Not yet recruiting
- Covid19
- Aerosolized 13 cis retinoic acid plus Inhalation administration by nebulization captopril 25mg
- Drug: Standard treatment Standard treatment
- (no location specified)
Oct 23, 2020
Chronic Pancreatitis, Genetic Mutation, Pregnancy Related Trial in Shanghai (genetic sequencing)
Active, not recruiting
- Chronic Pancreatitis
- +2 more
- genetic sequencing
-
Shanghai, Shanghai, ChinaChanghai Hospital
Sep 24, 2023
COVID19 Trial in Padova (Nafamostat Mesilate, Placebo)
Recruiting
- COVID19
- Nafamostat Mesilate
- Placebo
-
Padova, ItalyAzienda Ospedale Università di Padova
Jun 4, 2021
Liver Cancer Trial in Chang chun (FAPI PET)
Recruiting
- Liver Cancer
- FAPI PET
-
Chang chun, Jilin, ChinaChina-Japan Union Hospital
Mar 28, 2023
Hemophilia A, Hemophilia B Trial in China (Recombinant human activated coagulation factor VII for injection)
Recruiting
- Hemophilia A
- Hemophilia B
- Recombinant human activated coagulation factor VII for injection
-
Chongqing, Chongqing, China
- +8 more
Aug 2, 2022
Protease Activated Receptor-2 and Gastrointestinal Dysfunction
Recruiting
- Gastroparesis
- +2 more
-
Boston, MassachusettsBoston Children's Hospital
Mar 10, 2022
Opioid Use Disorder, Substance Use Disorder Trial (Treatment as Usual (TAU) (Arm 1), Peer Recovery Support Services (PRSS) + TAU
Not yet recruiting
- Opioid Use Disorder
- Substance Use Disorder
- Treatment as Usual (TAU) (Arm 1)
- Peer Recovery Support Services (PRSS) + TAU (experimental- Arm 2)
- (no location specified)
Nov 7, 2022
Atherosclerosis Trial in Beijing (68Ga-FAPI)
Recruiting
- Atherosclerosis
-
Beijing, ChinaPeking Union Medical College Hospital
Sep 6, 2021
Type 1 Diabetic Nephropathy Trial in Cairo (oral sitagliptin supplementation)
Completed
- Type 1 Diabetic Nephropathy
- oral sitagliptin supplementation
-
Cairo, EgyptNancy Elbarbary
Nov 2, 2023
Hepatectomy Trial in Hangzhou (rhThrombin ( Topical ), )
Completed
- Hepatectomy
- rhThrombin ( Topical )
- placebo
-
Hangzhou, Zhejiang, ChinaZhiwei Li
Apr 9, 2021
Digestive Health, Gastrointestinal Health, Appetitive Behavior Trial in Montréal (OPTIZIOME® P³ HYDROLYZER® - WHEY, Placebo)
Not yet recruiting
- Digestive Health
- +2 more
- OPTIZIOME® P³ HYDROLYZER® - WHEY
- Placebo
-
Montréal, Quebec, CanadaMcGill University, Currie Gymnasium (Exercise Metabolism and Nut
Jul 21, 2023
Hepatitis C Virus Infection Trial (OBV/PTV/r) ± ribavirin (RBV))
Completed
- Hepatitis C Virus Infection
- OBV/PTV/r) ± ribavirin (RBV)
- (no location specified)
May 9, 2020
Covid19 Trial in France (Camostat Mesylate, Placebo)
Terminated
- Covid19
- Camostat Mesylate
- Placebo
-
Argenteuil, France
- +5 more
Jan 27, 2022
Chronic Hepatitis C Virus Infection Trial in Beni-Suef (SOF plus (OBV/PTV/r) plus RBV)
Completed
- Chronic Hepatitis C Virus Infection
- SOF plus (OBV/PTV/r) plus RBV
-
Beni-Suef, EgyptBeni-Suef University
May 13, 2020
Fibroblast Activation Protein Inhibitor, PET/CT, Malignant Tumor Trial in Wuhan (68Ga-FAPI, PET/CT)
Recruiting
- Fibroblast Activation Protein Inhibitor
- +2 more
- 68Ga-FAPI
- PET/CT
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Aug 27, 2021
Malignant Glioma, Glioblastoma Trial in Durham (Evolocumab)
Recruiting
- Malignant Glioma
- Glioblastoma
-
Durham, North CarolinaDuke University Medical Center
Oct 13, 2022
Sepsis Syndrome, MODS, AKI Trial in Xi'an
Not yet recruiting
- Sepsis Syndrome
- +5 more
-
Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xian JiaotongUniversity
May 18, 2022
Pancreatitis, Chronic; Diabetes; Transplant Trial in Minneapolis (etanercept, Alpha 1-Antitrypsin)
Active, not recruiting
- Pancreatitis, Chronic; Diabetes; Transplant
- etanercept
- Alpha 1-Antitrypsin
-
Minneapolis, MinnesotaUniversity of Minnesota
Aug 12, 2022
Corona Virus Infection Trial in Denmark, Sweden (Camostat Mesilate, Placebo oral tablet)
Recruiting
- Corona Virus Infection
- Camostat Mesilate
- Placebo oral tablet
-
Hjørring, Region Nord, Denmark
- +10 more
Apr 27, 2021
Crohn Disease Trial in Ann Arbor (Low serine diet, High serine diet)
Recruiting
- Crohn Disease
- Low serine diet
- High serine diet
-
Ann Arbor, MichiganUniversity of Michigan
May 19, 2022